US 6656915
Inhibiting T-cell proliferation
expired A61KA61K31/505A61K31/708
Quick answer
US patent 6656915 (Inhibiting T-cell proliferation) held by BioCryst Pharmaceuticals, Inc. expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/505, A61K31/708